Akso Health Group
AHG
4 hedge funds and large institutions have $590K invested in Akso Health Group in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 3 reducing their positions, and 3 closing their positions.
2.43% more ownership
Funds ownership: 0% → 2.43% (+2.4%)
43% less funds holding
Funds holding: 7 → 4 (-3)
54% less capital invested
Capital invested by funds: $1.28M → $590K (-$689K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$109K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$62K |
| 3 |
VF
Virtu Financial
New York
|
-$20K |
| 4 |
Jane Street
New York
|
-$18K |
| 5 |
Two Sigma Investments
New York
|
-$16K |
AHG Hedge Fund Activity: Q2 2022 in Review
4 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q2 2022, worth a combined $590K — down 54% from $1.28M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of AHG and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 0 added.
The largest seller was Renaissance Technologies, cutting an estimated $109K.
- 4 institutional investors held Akso Health Group (AHG) as of Q2 2022, down from 7 in Q1 2022.
- Funds reported $590K of Akso Health Group stock for Q2 2022, down 54% quarter-over-quarter.
- 0 funds opened new Akso Health Group positions in Q2 2022 and 3 closed out, a net change of -3 holders.
- The largest Akso Health Group seller in Q2 2022 was Renaissance Technologies, an estimated $109K sold.
Based on aggregated 13F filings for Q2 2022.